AI-generated summary
The authors report a prospective study of 15 healthy adults with mild to moderate facial acne scars, treated three times monthly with a fractional bipolar radiofrequency device, and 10 completed the study. Physician-assessed scar severity was significantly reduced at 1 and 3 months, with adverse effects limited mainly to transient erythema. The small sample size and lack of a control group limit the strength of these findings.
- Participants
- 15
- Who or what was studied
- Healthy adults with mild to moderate facial acne scars, aged 35.7 ± 5.6 years on average, 13 of 15 female, skin types I-V
- Limits stated in the abstract
- Small sample of 15 enrolled with only 10 completing the study, and the abstract reports no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.